Quipt Home Medical Corp. (NASDAQ:QIPT) is a company that provides in-home monitoring and disease management services. It focuses on patients with chronic conditions, offering a range of medical equipment and supplies. Despite its niche market, QIPT faces competition from other healthcare service providers.
On December 15, 2025, QIPT reported an earnings per share (EPS) of -$0.08, missing the estimated EPS of $0.03. The company's revenue was $68.3 million, falling short of the expected $105 million. Despite this, the stock saw a 34.1% increase, opening at $3.50 the following day, as highlighted by the surge in options trading activity.
The surge in options trading saw 5,781 call options purchased, a significant increase from the average of 418. This activity likely contributed to the stock's price increase. The company's market capitalization stands at $152 million, with a beta of 0.59, indicating lower volatility compared to the market.
Financially, QIPT has a quick ratio of 0.75 and a current ratio of 1.15, suggesting it can cover its short-term liabilities. The debt-to-equity ratio is 0.71, showing moderate leverage. However, the negative price-to-earnings ratio of -14.75 and negative earnings yield of -6.78% indicate ongoing financial challenges.
QIPT's price-to-sales ratio is 0.61, and its enterprise value to sales ratio is 0.93, reflecting how the market values its sales and overall valuation. The enterprise value to operating cash flow ratio is 6.73, suggesting the company is valued at 6.73 times its operating cash flow, which is a key metric for assessing financial health.
